Intrested in learning more about a news, or intrested in participating
in a clinical news?
Clinical trials are enrolling now for COVID-19 at Centex Studies, Inc.
McAllen, TX – Talk of potential treatment options for COVID-19 have been in the news over the past few weeks, with focus on some more than others. Now, local McAllen physicians are putting these options to the test.
“We’re looking at an investigational treatment option that is showing promise in some patient populations,” says Dr. Joel Solis, Principle Investigator of Centex Studies in McAllen. “Our team is currently evaluating whether or not this particular treatment can help speed up the recovery process for those diagnosed with COVID-19.”
COVID-19, or coronavirus, has killed over 115,000 people in the US and 408,000 worldwide. Physicians and researchers are working around the clock and pulling out all the stops in attempts of finding something that can slow or stop the spread of the deadly virus.
“We know that finding a treatment is imperative as we continue to see an influx in cases,” says Dr. Solis. “It’s important that we do our due diligence in the clinical trial process to be sure that what we give our patients is safe and effective.”
Dr. Solis says that without properly testing a treatment, more harm than good could be done.
Centex Studies is one of the first research facilities evaluating treatment options for COVID-19, a process that can take upwards of a year or more.
“Our goal is clear; to save lives,” says Dr. Solis. “We’ll continue in our fight and do our part to help those in our community and around the world.”
To learn more about this clinical trial, Aleida Espinoza at 281-918-0048.
About Centex Studies
Houston 1045 Gemini St. Ste. 200-A
Houston, TX 77058
For Life-Threatening Emergencies
Call 911 or 832-457-2167
© 2019 by Centex Studies,Inc